MediPharm Labs Corp. (TSE:LABS – Get Free Report) shares reached a new 52-week high on Monday . The stock traded as high as C$0.12 and last traded at C$0.11, with a volume of 453968 shares traded. The stock had previously closed at C$0.11.
MediPharm Labs Stock Performance
The company has a market capitalization of C$41.50 million, a P/E ratio of -3.44 and a beta of 0.88. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10. The business’s 50-day moving average price is C$0.07 and its two-hundred day moving average price is C$0.07.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- How to Start Investing in Real Estate
- Energy Transfer: Powering Data With Dividends and Diversification
- Dividend Capture Strategy: What You Need to Know
- Qualcomm Stock Is Coiling for a Breakout
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
